Interaction with σ1 Protein, but Not N-Methyl-d-aspartate Receptor, Is Involved in the Pharmacological Activity of Donepezil

Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>

Sharon L. Rogers · Archives of Internal Medicine · 1998 · 778 citations

Medicine, Pharmacology, Pharmacotherapy +16

The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial

Sharon L. Rogers, Lawrence Friedhoff · Dementia and Geriatric Cognitive Disorders · 1996 · 741 citations

Medicine, Pharmacology, Pharmacotherapy +17

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

Bengt Winblad, Knut Engedal, Hilkka Soininen et al. · Neurology · 2001 · 731 citations

Medicine, Pharmacology, Pharmacotherapy +16

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

Richard C. Mohs, Rachelle S. Doody, John C. Morris et al. · Neurology · 2001 · 507 citations

Medicine, Neurology, Pharmacotherapy +17

Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study

Samantha Rogers, Rachelle S. Doody, Raymond Pratt et al. · European Neuropsychopharmacology · 2000 · 268 citations

Medicine, Pharmacology, Psychiatry +15